Related Experiment Video
Updated: Jul 11, 2026
06:41
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
12.5K
Anticoagulation during extracorporeal membrane oxygenation: A narrative review
John R Priest1, David Hebert2,3, Camille Jutras4
1ECMO Program, Department of Respiratory Care, Lifespan Hospital System, Providence, RI, USA.
Perfusion
|April 27, 2024
Summary
Optimizing anticoagulation for Extracorporeal Membrane Oxygenation (ECMO) is crucial. This review examines hemostasis, anticoagulation agents like unfractionated heparin (UHF) and direct thrombin inhibitors (DTIs), and monitoring methods for ECMO patients.
Area of Science:
- Cardiovascular Medicine
- Critical Care Medicine
- Hematology
Background:
- Extracorporeal Membrane Oxygenation (ECMO) provides vital organ support for critically ill patients.
- Patients on ECMO face significant risks of bleeding and thrombosis despite technological advancements.
- Effective anticoagulation is essential but optimal strategies remain debated.
Purpose of the Study:
- To review the complexities of hemostasis in ECMO patients.
- To compare unfractionated heparin (UHF) and Direct Thrombin Inhibitors (DTIs) for ECMO anticoagulation.
- To discuss coagulation monitoring tools and their limitations in the ECMO setting.
Main Methods:
- Narrative review of current literature on ECMO and hemostasis.
- Analysis of the impact of ECMO circuit characteristics on coagulation.
- Evaluation of different anticoagulation agents and monitoring techniques.
Main Results:
- Hematologic complications, including bleeding and thrombosis, are common in ECMO patients.
- Both UHF and DTIs have distinct benefits and drawbacks for anticoagulation.
- Current coagulation tests have limitations in accurately guiding ECMO anticoagulation.
Conclusions:
- Determining the optimal anticoagulation strategy for ECMO remains an ongoing challenge.
- Further research is necessary to establish best practices for anticoagulation and monitoring.
- Individualized approaches considering patient factors and circuit specifics may be required.
Related Concept Videos
01:30Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...